All things considered, it’s at least as likely to make health outcomes worse as it is to make most people healthier.

NeuroPace, Inc. (NASDAQ:NPCE), a medical device company specializing in neurological disorders with a market capitalization of $439 million, has been making significant strides in the epilepsy ...

Beta CEO Marcel Botha talks about the FDA’s plans for medical shortage notifications and how Trump’s policies may impact US ...

The FDA’s Webinar for Manufacturers and Other Interested Parties - The U.S. Food and Drug Administration (FDA) will host a webinar ...

The Health and Human Services Office of Inspector General has found that, in a few cases, FDA officials veered from the accelerated approval pathway.

The Food & Drug Administration (FDA), has quietly taken down their guidance detailing diversity action plans for clinical ...

The law would require businesses to have signage advertising the kits in addition to offering the testing strips.

Among the wave of guidance documents issued by the U.S. Food and Drug Administration (“FDA” or the “Agency”) in the first week of 2025 were ...

The website changes raise concerns about “the interference of politics with the study and the practice” of science and ...

If you have a microcurrent device on your wishlist, here are some benefits and drawbacks to consider before you buy one.

Brenner, who worked in the FDA’s Center for Devices and Radiological Health, will take the helm of the agency until a new ...

In the final days of the Biden Administration, the United States Food and Drug Administration (FDA) issued final guidance on ...